The Study of Clinical Phenotypes and Analysis of Mutations in L1 Syndrome

Overview

Journal Ann Neurosci

Publisher Sage Publications

Specialty Neurology

Date 2025 Mar 3

PMID 40026328

Authors

Madhan Shrinivasamurthy

Shreeshail V Benakanal

Nagaraj Kakanahalli

Affiliations

Soon will be listed here.

Abstract

Background: L1CAM protein plays a crucial role during early development and mutations in L1CAM cause L1 syndrome. L1 syndrome demonstrates a highly variable presentation within and between families. The clinical symptoms of L1 syndrome include mental retardation, hydrocephalus, spasticity, aphasia, and adducted thumb. Mutations in gene were found to affect structurally essential key residues in extracellular region of L1 leading to changes in protein binding properties. In most cases, these mutations create unexpected phenotypes which need to be understood thoroughly.

Purpose: The L1 syndrome patients were identified by various phenotypes like mental retardation, hydrocephalus, aphasia, spasticity, adducted thumb, etc., and the patients or mental retardation (MR) children who had more than three symptoms. This study aimed to screen mutations in multiple exons by Sanger sequencing.

Methods: The present study employed primers which are designed for specific exons of gene to amplify and sequence the amplified product to detect the mutations in L1 syndrome patients by the Sanger sequencing. Chi-square test was used to determine the mutation detection rate with the number of L1 syndrome phenotypes and several i programs were used to investigate potential effects of the variants.

Results: The nine different mutations in six patients. The mutation detection rate was high (83.33%) in patients with more than one L1 syndrome phenotype and in patients with more than one affected member in a family compared to patients with single phenotypes and negative family history (16.6%).

Conclusion: The mutation detection rate was related to the presence of typical L1 syndrome phenotypes and the family history. Screening of gene mutations in the Indian population is much needed to analyze the mutations and understand the mechanism underlying L1 disease. The present study has identified some novel mutations which are implicated in alterations in various biological functions during development leading to pathogenesis of L1 syndrome.

References

Basel-Vanagaite L, Straussberg R, Friez M, Inbar D, Korenreich L, Shohat M . Expanding the phenotypic spectrum of L1CAM-associated disease. Clin Genet. 2006; 69(5):414-9. DOI: 10.1111/j.1399-0004.2006.00607.x. View

Adle-Biassette H, Saugier-Veber P, Fallet-Bianco C, Delezoide A, Razavi F, Drouot N . Neuropathological review of 138 cases genetically tested for X-linked hydrocephalus: evidence for closely related clinical entities of unknown molecular bases. Acta Neuropathol. 2013; 126(3):427-42. DOI: 10.1007/s00401-013-1146-1. View

Jouet M, Rosenthal A, Armstrong G, MacFarlane J, Stevenson R, Paterson J . X-linked spastic paraplegia (SPG1), MASA syndrome and X-linked hydrocephalus result from mutations in the L1 gene. Nat Genet. 1994; 7(3):402-7. DOI: 10.1038/ng0794-402. View

Hiraki Y, Okamoto N, Ida T, Nakata Y, Kamada M, Kanemura Y . Two new cases of pure 1q terminal deletion presenting with brain malformations. Am J Med Genet A. 2008; 146A(10):1241-7. DOI: 10.1002/ajmg.a.32275. View

Van Camp G, Vits L, Coucke P, Lyonnet S, Schrander-Stumpel C, Darby J . A duplication in the L1CAM gene associated with X-linked hydrocephalus. Nat Genet. 1993; 4(4):421-5. DOI: 10.1038/ng0893-421. View

Rodriguez Criado G, Perez Aytes A, Martinez F, Vos Y, Verlind E, Lopez A . X-linked hydrocephalus: another two families with an L1 mutation. Genet Couns. 2003; 14(1):57-65. View

Fransen E, Van Camp G, DHooge R, Vits L, Willems P . Genotype-phenotype correlation in L1 associated diseases. J Med Genet. 1998; 35(5):399-404. PMC: 1051314. DOI: 10.1136/jmg.35.5.399. View

De Angelis E, Watkins A, Schafer M, Brummendorf T, Kenwrick S . Disease-associated mutations in L1 CAM interfere with ligand interactions and cell-surface expression. Hum Mol Genet. 2002; 11(1):1-12. DOI: 10.1093/hmg/11.1.1. View

Du Y, Srivastava A, Schwartz C . Multiple exon screening using restriction endonuclease fingerprinting (REF): detection of six novel mutations in the L1 cell adhesion molecule (L1CAM) gene. Hum Mutat. 1998; 11(3):222-30. DOI: 10.1002/(SICI)1098-1004(1998)11:3<222::AID-HUMU7>3.0.CO;2-J. View

10.

Weller S, Gartner J . Genetic and clinical aspects of X-linked hydrocephalus (L1 disease): Mutations in the L1CAM gene. Hum Mutat. 2001; 18(1):1-12. DOI: 10.1002/humu.1144. View

11.

Yamasaki M, Thompson P, LEMMON V . CRASH syndrome: mutations in L1CAM correlate with severity of the disease. Neuropediatrics. 1997; 28(3):175-8. PMC: 1563987. DOI: 10.1055/s-2007-973696. View

12.

Bertolin C, Boaretto F, Barbon G, Salviati L, Lapi E, Divizia M . Novel mutations in the L1CAM gene support the complexity of L1 syndrome. J Neurol Sci. 2010; 294(1-2):124-6. DOI: 10.1016/j.jns.2010.03.030. View

13.

Coucke P, Vits L, Van Camp G, Serville F, Lyonnet S, Kenwrick S . Identification of a 5' splice site mutation in intron 4 of the L1CAM gene in an X-linked hydrocephalus family. Hum Mol Genet. 1994; 3(4):671-3. DOI: 10.1093/hmg/3.4.671. View

14.

Cheng L, Lemmon V . Pathological missense mutations of neural cell adhesion molecule L1 affect neurite outgrowth and branching on an L1 substrate. Mol Cell Neurosci. 2004; 27(4):522-30. DOI: 10.1016/j.mcn.2004.08.005. View

15.

Finckh U, Schroder J, Ressler B, Veske A, Gal A . Spectrum and detection rate of L1CAM mutations in isolated and familial cases with clinically suspected L1-disease. Am J Med Genet. 2000; 92(1):40-6. DOI: 10.1002/(sici)1096-8628(20000501)92:1<40::aid-ajmg7>3.0.co;2-r. View

16.

Kanemura Y, Okamoto N, Sakamoto H, Shofuda T, Kamiguchi H, Yamasaki M . Molecular mechanisms and neuroimaging criteria for severe L1 syndrome with X-linked hydrocephalus. J Neurosurg. 2007; 105(5 Suppl):403-12. DOI: 10.3171/ped.2006.105.5.403. View

17.

Haspel J, Grumet M . The L1CAM extracellular region: a multi-domain protein with modular and cooperative binding modes. Front Biosci. 2003; 8:s1210-25. DOI: 10.2741/1108. View

18.

Isik E, Onay H, Atik T, Akgun B, Cogulu O, Ozkinay F . Clinical and genetic features of L1 syndrome patients: Definition of two novel mutations. Clin Neurol Neurosurg. 2018; 172:20-23. DOI: 10.1016/j.clineuro.2018.06.007. View

19.

Jackson S, Guner Y, Woo R, Randolph L, Ford H, Shin C . L1CAM mutation in association with X-linked hydrocephalus and Hirschsprung's disease. Pediatr Surg Int. 2009; 25(9):823-5. PMC: 2734257. DOI: 10.1007/s00383-009-2420-0. View

20.

Ochando I, Vidal V, Gascon J, Acien M, Urbano A, Rueda J . Prenatal diagnosis of X-linked hydrocephalus in a family with a novel mutation in L1CAM gene. J Obstet Gynaecol. 2015; 36(3):403-5. DOI: 10.3109/01443615.2015.1086982. View